Does Stereotactic Radiosurgery Have a Role in the Management of Patients Presenting With 4 or More Brain Metastases?

Overview

Journal Neurosurgery

Specialty Neurosurgery

Date 2018 Jun 4

PMID 29860451

Citations 18

Authors

Michael H Soike

Ryan T Hughes

Michael Farris

Emory R McTyre

Christina K Cramer

J D Bourland

Michael D Chan

Affiliations

Soon will be listed here.

Abstract

Stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) are effective treatments for management of brain metastases. Prospective trials comparing the 2 modalities in patients with fewer than 4 brain metastases demonstrate that overall survival (OS) is similar. Intracranial failure is more common after SRS, while WBRT is associated with neurocognitive decline. As technology has advanced, fewer technical obstacles remain for treating patients with 4 or more brain metastases with SRS, but level I data supporting its use are lacking. Observational prospective studies and retrospective series indicate that in patients with 4 or more brain metastases, performance status, total volume of intracranial disease, histology, and rate of development of new brain metastases predict outcomes more accurately than the number of brain metastases. It may be reasonable to initially offer SRS to some patients with 4 or more brain metastases. Initiating therapy with SRS avoids the acute and late sequelae of WBRT. Multiple phase III trials of SRS vs WBRT, both currently open or under development, are directly comparing quality of life and OS for patients with 4 or more brain metastases to help answer the question of SRS appropriateness for these patients.

Citing Articles

Treatment Options for Brain Metastases.

Choi A, Hunting J, Lanier C, Douglas E, Triozzi P, Ruiz J Curr Treat Options Oncol. 2024; 25(8):1011-1026.

PMID: 39037617 PMC: 11329393. DOI: 10.1007/s11864-024-01195-3.

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.

Abdulhaleem M, Hunting J, Wang Y, Smith M, Agostino R, Lycan T Front Oncol. 2023; 13:1214126.

PMID: 38023147 PMC: 10661935. DOI: 10.3389/fonc.2023.1214126.

Survival and Radiation Dose Differences Between Single Versus Multi-Session Gamma Knife Stereotactic Radiosurgery in Patients Treated for Multiple (≥10) Brain Metastases.

Stambaugh C, Wang A, Kim E, Mignano J, Melhus C, Rodrigues R Cureus. 2023; 15(10):e46901.

PMID: 37954747 PMC: 10638890. DOI: 10.7759/cureus.46901.

Fractionated Stereotactic Radiotherapy with Helical Tomotherapy for Brain Metastases: A Mono-Institutional Experience.

Cuccia F, DAlessandro S, Carruba G, Figlia V, Spera A, Cespuglio D J Pers Med. 2023; 13(7).

PMID: 37511711 PMC: 10381210. DOI: 10.3390/jpm13071099.

Radiological Biomarkers for Brain Metastases Prognosis: Quantitative Magnetic Resonance Imaging (MRI) Modalities As Non-invasive Biomarkers for the Effect of Radiotherapy.

Eraky A Cureus. 2023; 15(4):e38353.

PMID: 37266043 PMC: 10229388. DOI: 10.7759/cureus.38353.

References

Attia A, Page B, Lesser G, Chan M . Treatment of radiation-induced cognitive decline. Curr Treat Options Oncol. 2014; 15(4):539-50. DOI: 10.1007/s11864-014-0307-3. View

Urbanic J . The Demise of Whole-Brain Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017; 99(5):1064-1066. DOI: 10.1016/j.ijrobp.2017.08.040. View

Sawrie S, Guthrie B, Spencer S, Nordal R, Meredith R, Markert J . Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2007; 70(1):181-6. DOI: 10.1016/j.ijrobp.2007.05.084. View

Lester S, Taksler G, Kuremsky J, Lucas Jr J, Ayala-Peacock D, Randolph 2nd D . Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer. 2014; 120(3):433-41. PMC: 9168957. DOI: 10.1002/cncr.28422. View

Chao S, de Salles A, Hayashi M, Levivier M, Ma L, Martinez R . Stereotactic Radiosurgery in the Management of Limited (1-4) Brain Metasteses: Systematic Review and International Stereotactic Radiosurgery Society Practice Guideline. Neurosurgery. 2017; 83(3):345-353. DOI: 10.1093/neuros/nyx522. View

Hughes R, Black P, Page B, Lucas Jr J, Qasem S, Watabe K . Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. J Radiosurg SBRT. 2018; 4(2):89-96. PMC: 5658880. View

Chang E, Wefel J, Hess K, Allen P, Lang F, Kornguth D . Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009; 10(11):1037-44. DOI: 10.1016/S1470-2045(09)70263-3. View

Halasz L, Weeks J, Neville B, Taback N, Punglia R . Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys. 2012; 85(2):e109-16. PMC: 3728282. DOI: 10.1016/j.ijrobp.2012.08.007. View

Lutterbach J, Cyron D, Henne K, Ostertag C . Radiosurgery followed by planned observation in patients with one to three brain metastases. Neurosurgery. 2008; 62 Suppl 2:776-84. DOI: 10.1227/01.neu.0000316281.07124.ea. View

10.

Lagerwaard F, Levendag P, Nowak P, Eijkenboom W, Hanssens P, Schmitz P . Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43(4):795-803. DOI: 10.1016/s0360-3016(98)00442-8. View

11.

Peiffer A, Leyrer C, Greene-Schloesser D, Shing E, Kearns W, Hinson W . Neuroanatomical target theory as a predictive model for radiation-induced cognitive decline. Neurology. 2013; 80(8):747-53. PMC: 3589296. DOI: 10.1212/WNL.0b013e318283bb0a. View

12.

Minniti G, Clarke E, Lanzetta G, Osti M, Trasimeni G, Bozzao A . Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011; 6:48. PMC: 3108308. DOI: 10.1186/1748-717X-6-48. View

13.

Brown P, Jaeckle K, Ballman K, Farace E, Cerhan J, Anderson S . Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA. 2016; 316(4):401-409. PMC: 5313044. DOI: 10.1001/jama.2016.9839. View

14.

Farris M, McTyre E, Cramer C, Hughes R, Randolph 2nd D, Ayala-Peacock D . Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone. Int J Radiat Oncol Biol Phys. 2017; 98(1):131-141. DOI: 10.1016/j.ijrobp.2017.01.201. View

15.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K . Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006; 295(21):2483-91. DOI: 10.1001/jama.295.21.2483. View

16.

Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72. DOI: 10.1016/S0140-6736(04)16250-8. View

17.

Flickinger J, Kondziolka D, Pollock B, Maitz A, Lunsford L . Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling. Int J Radiat Oncol Biol Phys. 1997; 38(3):485-90. DOI: 10.1016/s0360-3016(97)89481-3. View

18.

Ayala-Peacock D, Peiffer A, Lucas J, Isom S, Kuremsky J, Urbanic J . A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014; 16(9):1283-8. PMC: 4136890. DOI: 10.1093/neuonc/nou018. View

19.

Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Barfod B . A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article. J Neurosurg. 2013; 118(6):1258-68. DOI: 10.3171/2013.3.JNS121900. View

20.

Blonigen B, Steinmetz R, Levin L, Lamba M, Warnick R, Breneman J . Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2009; 77(4):996-1001. DOI: 10.1016/j.ijrobp.2009.06.006. View